RxDoctor Payments Data

Janine Prime, NP

Adult Medicine · Manassas, VANPI 1669996062

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.

$3,390in general payments, 2019–2025

Across 162 payments — averaging $20.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$760
  • Pfizer$625
  • Amgen$354
  • Lilly USA, LLC$247
  • Exact Sciences$165
  • Bausch Health US, LLC$151
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,390 in reported general payments places this provider in the 75th percentile of 32 adult medicine providers in Virginia.

See all adult medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$66,234
Medicare patients
265
Services billed
962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynthroidLevothyroxine Sodium17$1,241
Metoprolol Succinate23$690
Rosuvastatin Calcium32$656
ValacyclovirValacyclovir Hcl11$608
Olmesartan Medoxomil23$593
Duloxetine Hcl22$550
Atorvastatin Calcium58$542
Ezetimibe17$463
Omeprazole13$461
Levothyroxine Sodium36$384
Escitalopram Oxalate34$364
Hydrochlorothiazide43$202
Alprazolam18$143
Zolpidem Tartrate26$142
Lisinopril22$119

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$140$1,24117 claims
PfizerPaxlovid$625$013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 32 adult medicine providers in Virginia.

Other adult medicine in Manassas

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →